News und Analysen
EQS-News: PUMA shifts to licensing model with United Legwear Company LLC in the US and Canada
EQS-News: Hannover Re raises earnings guidance for 2025 after very good business performance
EQS-News: Higher organic sales growth in Q3 – positive volume development in both business units
EQS-News: Continental Reaches Key Milestones in Its Realignment
EQS-News: Zalando delivers strong Q3 growth with customer base surpassing 61 million; doubles down on sports opportunity, announcing partnership with German Football Federation
EQS-Adhoc: Zalando SE: Zalando Launches Share Buy-back for Share-based Remuneration Programs
EQS-News: Successful Eurobond Issuance: Vonovia places Bonds with Total Volume of EUR 2.25 billion
This Company Now Has the World's No. 1 Drug. Should You Invest $1,000?
Eli Lilly (NYSE: LLY) manufactures a drug called tirzepatide, a GLP-1 dual receptor agonist, which it sells as Mounjaro for treating type 2 diabetes and Zepbound for weight loss. Tirzepatide became
EQS-News: Dynamic growth: Vonovia returns to pre-crisis levels
Why Merck Is Sinking This Week
The stock for pharmaceutical giant Merck (NYSE: MRK) was trading down more than 3% Monday morning. That's a big drop in just a few hours to start the week.
So, what's going on?
It might have to do
EQS-Adhoc: Airbus reports share buybacks for week starting 27 October 2025
EQS-News: PUMA enters reset phase in Q3 and outlines strategic priorities
Massive News: QuantumScape's Earnings Could Spark the Next Electric Vehicle (EV) Boom
QuantumScape (NYSE: QS) continues to surprise the market with groundbreaking solid-state battery technology and a key partnership with Volkswagen's PowerCo. With liquidity secured through 2029 and
EQS-Adhoc: Airbus SE: Airbus reports Nine-Month (9m) 2025 results
EQS-News: Zalando Appoints Anna Dimitrova as CFO, Adding Wealth of Experience in Finance, Strategy, M&A and Transformation, to Management Board
EQS-Adhoc: BASF SE: BASF to begin share buyback program in November 2025
EQS-News: Symrise Reports Third Quarter 2025 Sales
3 Healthcare Stocks to Buy Hand Over Fist in October
If you are looking for a healthcare stock to add to your portfolio as October draws to a close, consider Intuitive Surgical (NASDAQ: ISRG), Merck (NYSE: MRK), and Johnson & Johnson (NYSE: JNJ). Each
EQS-News: PUMA reorganizes Brand Marketing and appoints Maria Valdes as Chief Brand Officer
EQS-News: PUMA appoints Ronald Reijmers as Vice President Global Retail
EQS-Adhoc: adidas reports strong third quarter results and increases its full-year outlook
2 Beaten-Down Stocks to Buy and Hold for the Next Decade
The market is forward-looking, but investors who earn better-than-average returns often look even further into the future and identify opportunities that are currently being overlooked. That means
EQS-News: E+S Rück anticipates a stable market environment in Germany for 2026 and continued growth in demand for reinsurance protection
7 Driverless Vehicle Stocks That Could Set You Up for Life
The driverless vehicle market has the potential for explosive growth over the next two decades driven by technological advancements, safety improvements, and commercial applications and could be
EQS-Adhoc: Continental AG: Continental announces preliminary figures for the third quarter of 2025 – adjusted EBIT margin as well as adjusted free cash flow above market expectations